About this trial
Unilateral conductive hearing loss (UCHL) in the presence of an intact tympanic membrane represents a diagnostic challenge in otologic practice. In the absence of middle ear effusion or tympanic membrane pathology, stapes fixation secondary to otosclerosis is often considered the most probable diagnosis. However, although otosclerosis is traditionally regarded as a bilateral disease, clinical presentation may be unilateral due to asymmetric disease progression or subclinical contralateral involvement. Other etiologies, including congenital ossicular anomalies, ossicular discontinuity, tympanosclerosis without tympanic membrane involvement, or oval window abnormalities, may mimic otosclerosis both clinically and audiologically. Consequently, exploratory tympanotomy remains the gold standard for definitive diagnosis, allowing direct assessment of ossicular chain mobility and confirmation of stapes fixation. Correlating preoperative clinical suspicion with intraoperative findings is therefore essential to better define the true causes of unilateral conductive hearing loss with an intact tympanic membrane.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
unilateral conductive hearing loss or mixed HL with intact Tympanic Membrane
Average Airborne Gap Above 20 decibels
Disqualifiers
Sensorineural hearing loss
Chronic otitis media
TM perforation
Previous ear surgery
Trial design
Single group
Treatments tested in this trial
Exporlation Tympanotomy
Procedure/Surgeryexploration tympanotomy of the middle ear and ossicles to diagnose or detect actual causes of conductive hearing loss and correct it according to the cause
Treatment groups
Trial outcomes
Primary outcomes
Improvement of the Airborne ( conductive ) gap
Difference between preoperative and postoperative Average Airbone gap in dicebel
Sponsors and contacts
Click on the lead sponsor to view all of their trials.